Bomed Medical Manufacturing Ltd., an Irvine maker of cardiovascular monitoring instruments, continued an unprofitable year with a net loss of $119,280 for the second fiscal quarter ended May 31, contrasted with net income of $141,000 last year. Revenues were $288,670, down 51% from $590,130 last year.
For the first half, Bomed lost $327,060 on revenues of $440,040.
A company official attributed the second quarter loss to the company's investment in training a national sales force affiliated with National Medical Specialties, which was recently signed as a non-exclusive distributor of Bomed's cardiac output monitoring products. Last quarter's loss was attributed to high research spending.